Sandoz Group AG (0SAN.L)

CHF 36.12

(0.94%)

EBITDA Summary of Sandoz Group AG

  • Sandoz Group AG's latest annual EBITDA in 2023 was 857 Million USD , down -56.49% from previous year.
  • Sandoz Group AG's latest quarterly EBITDA in 2024 Q2 was 270.5 Million USD , down 0.0% from previous quarter.
  • Sandoz Group AG reported an annual EBITDA of 1.53 Billion USD in 2022, down -8.57% from previous year.
  • Sandoz Group AG reported an annual EBITDA of 1.67 Billion USD in 2021, up 30.77% from previous year.
  • Sandoz Group AG reported a quarterly EBITDA of 270.5 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Sandoz Group AG reported a quarterly EBITDA of 50.5 Million USD for 2023 Q3, down -83.72% from previous quarter.

Annual EBITDA Chart of Sandoz Group AG (2023 - 2020)

Historical Annual EBITDA of Sandoz Group AG (2023 - 2020)

Year EBITDA EBITDA Growth
2023 857 Million USD -56.49%
2022 1.53 Billion USD -8.57%
2021 1.67 Billion USD 30.77%
2020 1.28 Billion USD 0.0%

Peer EBITDA Comparison of Sandoz Group AG

Name EBITDA EBITDA Difference
Relief Therapeutics Holding AG -108.2 Million CHF 892.037%
Tecan Group AG 205.57 Million CHF -316.882%
Santhera Pharmaceuticals Holding AG 79.17 Million CHF -982.426%
Basilea Pharmaceutica AG 29.49 Million CHF -2805.577%
Bachem Holding AG 163.27 Million CHF -424.878%
Siegfried Holding AG 241.21 Million CHF -255.28%
Molecular Partners AG -59.51 Million CHF 1539.973%